A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination.
Journal: European Journal Of Case Reports In Internal Medicine
Published:
Abstract
: Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.
Conclusions: Guillain-Barré Syndrome (GBS) is a very rare complication after vaccination against SARS-CoV-2.The key concepts related to the understanding, management and outcomes of patients with GBS are discussed.
Authors
Yash Kripalani, Vidyadhara Lakkappan, Lipeeka Parulekar, Anjum Shaikh, Rakesh Singh, Pradeep Vyas
Relevant Conditions